Milestone Pharmaceuticals Inc

NASDAQ:MIST   3:59:44 PM EDT
6.08
+0.14 (+2.36%)
Earnings Announcements

Milestone Pharmaceuticals Posts Qtrly Loss Per Share $0.30

Published: 05/17/2021 11:27 GMT
Milestone Pharmaceuticals Inc (MIST) - Milestone Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical, Regulatory, and Corporate Update.
Milestone Pharmaceuticals Inc - Qtrly Loss per Share $0.30.
Revenue is expected to be $5 Million
Adjusted EPS is expected to be -$0.26

Next Quarter Revenue Guidance is expected to be $5 Million
Next Quarter EPS Guidance is expected to be -$0.32

More details on our Analysts Page.